Classifications

• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07D—HETEROCYCLIC COMPOUNDS
  • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
  • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
  • C07D487/04—Ortho-condensed systems
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
  • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
  • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P11/00—Drugs for disorders of the respiratory system
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P13/00—Drugs for disorders of the urinary system
  • A61P13/08—Drugs for disorders of the urinary system of the prostate
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P13/00—Drugs for disorders of the urinary system
  • A61P13/12—Drugs for disorders of the urinary system of the kidneys
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P17/00—Drugs for dermatological disorders
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P25/00—Drugs for disorders of the nervous system
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
  • A61P31/12—Antivirals
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
  • A61P31/12—Antivirals
  • A61P31/14—Antivirals for RNA viruses
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
  • A61P31/12—Antivirals
  • A61P31/14—Antivirals for RNA viruses
  • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
  • A61P31/12—Antivirals
  • A61P31/14—Antivirals for RNA viruses
  • A61P31/18—Antivirals for RNA viruses for HIV
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
  • A61P31/12—Antivirals
  • A61P31/20—Antivirals for DNA viruses
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
  • A61P31/12—Antivirals
  • A61P31/20—Antivirals for DNA viruses
  • A61P31/22—Antivirals for DNA viruses for herpes viruses
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P35/00—Antineoplastic agents
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P35/00—Antineoplastic agents
  • A61P35/02—Antineoplastic agents specific for leukemia
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P37/00—Drugs for immunological or allergic disorders
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P37/00—Drugs for immunological or allergic disorders
  • A61P37/02—Immunomodulators
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P37/00—Drugs for immunological or allergic disorders
  • A61P37/02—Immunomodulators
  • A61P37/04—Immunostimulants
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P37/00—Drugs for immunological or allergic disorders
  • A61P37/02—Immunomodulators
  • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P37/00—Drugs for immunological or allergic disorders
  • A61P37/08—Antiallergic agents
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
  • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
  • C07F9/02—Phosphorus compounds
  • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
  • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K31/00—Medicinal preparations containing organic active ingredients
  • A61K31/33—Heterocyclic compounds
  • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
  • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
  • A61K31/4164—1,3-Diazoles
  • A61K31/4188—1,3-Diazoles condensed with other heterocyclic ring systems, e.g. biotin, sorbinil
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07D—HETEROCYCLIC COMPOUNDS
  • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
  • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings

Applications Claiming Priority (1)

Publications (1)

Family

ID=45976556

Family Applications (1)

Country Status (30)

Families Citing this family (241)

Family Cites Families (26)

• 2012
  • 2012-04-05 NO NO12767723A patent/NO2694640T3/no unknown
  • 2012-04-12 RS RS20180223A patent/RS56992B1/sr unknown
  • 2012-04-12 CN CN201510262906.5A patent/CN105111210B/zh active Active
  • 2012-04-12 DK DK12715295.7T patent/DK2697227T3/en active
  • 2012-04-12 PL PL12715295.7T patent/PL2697227T3/pl unknown
  • 2012-04-12 LT LTEP15197593.5T patent/LT3018132T/lt unknown
  • 2012-04-12 ME MEP-2016-82A patent/ME02417B/me unknown
  • 2012-04-12 PL PL15197593T patent/PL3018132T3/pl unknown
  • 2012-04-12 PT PT151975935T patent/PT3018132T/pt unknown
  • 2012-04-12 RU RU2017107026A patent/RU2017107026A/ru unknown
  • 2012-04-12 MX MX2013012021A patent/MX340442B/es active IP Right Grant
  • 2012-04-12 CN CN201280018684.7A patent/CN103547579B/zh active Active
  • 2012-04-12 NZ NZ708090A patent/NZ708090A/en unknown
  • 2012-04-12 HU HUE12715295A patent/HUE027316T2/en unknown
  • 2012-04-12 SI SI201230515A patent/SI2697227T1/sl unknown
  • 2012-04-12 RS RS20160285A patent/RS54723B1/en unknown
  • 2012-04-12 EP EP12715295.7A patent/EP2697227B1/en active Active
  • 2012-04-12 AU AU2012242871A patent/AU2012242871C1/en active Active
  • 2012-04-12 ES ES12715295.7T patent/ES2569665T3/es active Active
  • 2012-04-12 WO PCT/US2012/033245 patent/WO2012142237A1/en active Application Filing
  • 2012-04-12 KR KR1020137030438A patent/KR102164443B1/ko active IP Right Grant
  • 2012-04-12 PE PE2017002751A patent/PE20181023A1/es not_active Application Discontinuation
  • 2012-04-12 EP EP17205515.4A patent/EP3348558A1/en not_active Withdrawn
  • 2012-04-12 RU RU2013150811A patent/RU2613579C2/ru active
  • 2012-04-12 JP JP2014505274A patent/JP2014511876A/ja not_active Withdrawn
  • 2012-04-12 CA CA2833296A patent/CA2833296C/en active Active
  • 2012-04-12 PE PE2013002332A patent/PE20141124A1/es active IP Right Grant
  • 2012-04-12 ES ES15197593.5T patent/ES2660831T3/es active Active
  • 2012-04-12 BR BR112013026494A patent/BR112013026494A2/pt not_active Application Discontinuation
  • 2012-04-12 HU HUE15197593A patent/HUE038586T2/hu unknown
  • 2012-04-12 EP EP15197593.5A patent/EP3018132B1/en active Active
  • 2012-04-12 DK DK15197593.5T patent/DK3018132T3/en active
  • 2012-04-12 NZ NZ723271A patent/NZ723271A/en unknown
  • 2012-04-12 SI SI201231193T patent/SI3018132T1/en unknown
• 2013
  • 2013-10-14 IL IL228862A patent/IL228862A/en active IP Right Grant
  • 2013-10-14 US US14/053,440 patent/US9260434B2/en active Active
  • 2013-10-15 CL CL2013002990A patent/CL2013002990A1/es unknown
  • 2013-11-14 CO CO13268287A patent/CO6862146A2/es active IP Right Grant
• 2014
  • 2014-07-16 HK HK14107271.9A patent/HK1193822A1/zh unknown
  • 2014-12-10 AU AU2014274564A patent/AU2014274564B2/en active Active
  • 2014-12-22 JP JP2014258630A patent/JP5837673B2/ja active Active
• 2015
  • 2015-07-08 US US14/794,193 patent/US9388191B2/en active Active
  • 2015-09-24 IL IL241846A patent/IL241846A/en active IP Right Grant
  • 2015-11-05 JP JP2015217361A patent/JP6145491B2/ja active Active
• 2016
  • 2016-04-12 HR HRP20160369TT patent/HRP20160369T1/hr unknown
  • 2016-04-27 CY CY20161100355T patent/CY1117440T1/el unknown
  • 2016-05-04 SM SM201600130T patent/SMT201600130B/it unknown
  • 2016-06-13 US US15/181,062 patent/US9850248B2/en active Active
  • 2016-06-28 IL IL246515A patent/IL246515B/en active IP Right Grant
  • 2016-10-11 HK HK16111731.3A patent/HK1223371A1/zh unknown
  • 2016-12-20 AU AU2016277574A patent/AU2016277574B2/en active Active
• 2017
  • 2017-05-15 JP JP2017096307A patent/JP2017149769A/ja not_active Withdrawn
  • 2017-11-01 US US15/800,190 patent/US10233190B2/en active Active
• 2018
  • 2018-02-26 HR HRP20180335TT patent/HRP20180335T1/hr unknown
  • 2018-04-18 AU AU2018202706A patent/AU2018202706A1/en not_active Abandoned
  • 2018-12-03 HK HK18115442.2A patent/HK1256355A1/zh unknown
• 2019
  • 2019-02-07 US US16/269,681 patent/US20190225618A1/en not_active Abandoned

Also Published As

Similar Documents